By the end of 2027, driven by the demand to scale hyper-personalised patient experiences, improve collaboration, and foster equity, 60% of Asia/Pacific healthcare organisations will double GenAI investments, according to an IDC report. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
